Researchers Move Closer to Creating Blood Stem Cells in the Lab

Human blood stem cells

For years, scientists have tried to create human blood stem cells in the laboratory.

Researchers have succeeded in animal models several times. Replicating that achievement with human cells has proven much more difficult.

Now, a CIRM-funded team at the University of California, San Diego (UC San Diego) may have uncovered a critical piece of the puzzle.

Their discovery could one day expand access to life-saving blood stem cell transplants for patients with serious blood disorders and cancers.

The Search for Lab-Grown Blood Stem Cells

Blood stem cells produce all of the body’s blood cells.

They generate red blood cells that carry oxygen, white blood cells that fight infection, and platelets that help blood clot.

These cells also form the foundation of bone marrow transplantation, a treatment used for diseases such as leukemia and lymphoma.

Today, successful transplants often depend on finding a closely matched donor. Unfortunately, many patients never find a suitable match.

Researchers hope to solve that problem by creating blood stem cells in the laboratory.

If successful, scientists could produce a reliable supply of transplantable cells on demand.

Zebrafish

A Missing Piece of the Puzzle

The UC San Diego team discovered that blood stem cell development relies on three interacting molecules, not two.

To make the discovery, the researchers studied zebrafish.

Zebrafish create blood stem cells through a process similar to humans. Their transparent bodies also allow scientists to observe development in real time.

The team found that a signaling molecule called Wnt9a binds to a receptor known as Fzd9b.

The researchers then discovered a third essential player: the epidermal growth factor receptor (EGFR).

Together, these three molecules trigger the process that transforms a stem cell into a blood stem cell.

The finding suggests that previous attempts to create blood stem cells may have overlooked an important biological interaction.

“Previous attempts to develop blood stem cells in a laboratory dish have failed, and that may be in part because they didn’t take the interaction between EGFR and Wnt into account,” said Stephanie Grainger, first author of the study.

Expanding Access to Life-Saving Transplants

The discovery could help researchers develop more effective methods for generating blood stem cells in the laboratory.

If scientists can reliably produce these cells, they may eventually create off-the-shelf therapies for patients with blood cancers and other disorders.

Such therapies could reduce dependence on donor bone marrow and make treatment available to more patients.

Patients who cannot find a compatible donor could particularly benefit from this approach.

The research also deepens scientists’ understanding of how blood stem cells form during development, knowledge that may support future regenerative medicine therapies.

Looking Ahead

Researchers still face significant challenges before laboratory-grown blood stem cells become a clinical reality.

They must demonstrate that the cells function like natural blood stem cells and can safely rebuild the blood system after transplantation.

Even so, the discovery represents an important advance in a field that has pursued this goal for many years.

By identifying a previously overlooked molecular partnership, the UC San Diego team may have brought researchers one step closer to producing blood stem cells on demand.

Such a breakthrough could transform treatment for leukemia, lymphoma, and many other blood diseases.

The findings were published in Nature Cell Biology.

CIRM currently supports several additional programs involving blood stem cells, including therapies for Beta Thalassemia; blood cancer; HIV/AIDS; and Severe Combined Immunodeficiency,

Leave a Reply